NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...
Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...
Rootstock Software today announced that Tetra Pharm Technologies, a Danish biopharmaceutical company specializing in chronic pain, mental health, and obesity treatments, has selected Rootstock ERP to ...